Norbert W. Bischofberger
Amministratore Delegato presso KRONOS BIO, INC.
Patrimonio netto: 7 M $ in data 30/04/2024
Profilo
Norbert W.
Bischofberger is the founder of Rezo Therapeutics, Inc. (founded in 2022) where he holds the title of Director.
He is currently the President, Chief Executive Officer & Director at Kronos Bio, Inc. (since 2018), an Independent Director at Morphic Holding, Inc. (since 2019), a Director at Morphic Therapeutic, Inc. (since 2019), and a Scientific Advisor at VV Manager LLC.
Dr. Bischofberger previously held the position of Director at InCarda Therapeutics, Inc. He was the Chief Scientific Officer & Executive VP- Research at Gilead Sciences, Inc. from 2007 to 2018.
Prior to that, he was the Manager-DNA Synthesis Group at Genentech, Inc. from 1986 to 1990.
He also served as an Independent Member-Supervisory Board at Bayer AG from 2017 to 2024.
Dr. Bischofberger obtained his doctorate degree from the Swiss Federal Institute of Technology in 1983 and his undergraduate degree from the University of Innsbruck in 1980.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
KRONOS BIO INC
12.39% | 31/03/2024 | 7 445 248 ( 12.39% ) | 7 M $ | 30/04/2024 |
MORPHIC HOLDING, INC.
-.--% | 01/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Norbert W. Bischofberger
| Società | Posizione | Inizio |
|---|---|---|
| KRONOS BIO, INC. | Amministratore Delegato | 01/08/2018 |
| MORPHIC HOLDING, INC. | Direttore/Membro del Consiglio | 01/06/2019 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | 14/06/2019 |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Fondatore | 17/11/2022 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Consulente / Consigliere | - |
Precedenti posizioni note di Norbert W. Bischofberger
| Società | Posizione | Fine |
|---|---|---|
| BAYER AG | Direttore/Membro del Consiglio | 26/04/2024 |
| GILEAD SCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 30/04/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1990 |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Direttore/Membro del Consiglio | - |
Formazione di Norbert W. Bischofberger
| University of Innsbruck | Undergraduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| BAYER AG | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| KRONOS BIO, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Finance |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Norbert W. Bischofberger
